TAFINLARÂ® (dabrafenib) and MEKINISTÂ® (trametinib) are prescription medicines that can be used in combination to treat people with a type of skin cancer called melanoma. It should be used only for cancer patients whose cancer has specific gene mutation known as BRAF. MEKINIST Trametinib 2MG TABLETS are composed of active ingredient like trametinib. Offered medicines contain inactive ingredients like colloidal silicon dioxide, sodium lauryl sulphate and mannitol etc. These drugs are also advised for patients of non small cell lung cancer and thyroid cancer. These medicines are for oral administration purpose. These are prescribed by doctor to take 1 hour prior to or two hours after taking meal. These drugs are kinase inhibitors. Long storage life, immediate action, long lasting result and ease of administering are some main features of these medicines.